February 01, 1997; 48 (2) Brief Communication
Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon
Banu Anlar, Kalbiye Yalaz, Ferhunde Oktem, Gulsen Kose
First published February 1, 1997, DOI: https://doi.org/10.1212/WNL.48.2.526
Banu Anlar
Kalbiye Yalaz
Ferhunde Oktem
Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon
Banu Anlar, Kalbiye Yalaz, Ferhunde Oktem, Gulsen Kose
Neurology Feb 1997, 48 (2) 526-528; DOI: 10.1212/WNL.48.2.526
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 48 no. 2 526-528
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published February 1, 1997.
Copyright & Usage:
Copyright 1997 by Advanstar Communications Inc.
Author Disclosures
- Banu Anlar, MD,
- Kalbiye Yalaz, MD,
- Ferhunde Oktem, PhD and
- Gulsen Kose, MD
- Banu Anlar, MD,
- Kalbiye Yalaz, MD,
- Ferhunde Oktem, PhD and
- Gulsen Kose, MD
- From the Departments of Pediatric Neurology (Drs. Anlar and Yalaz) and Child Psychiatry (Dr. Oktem), Hacettepe University; and SSK Ankara Hospital (Dr. Kose), Ankara, Turkey.
- Supported by Hoffman-LaRoche and Schering-Plough, Turkey.
- Received April 11, 1996. Accepted in final form June 20, 1996.
- Address correspondence and reprint requests to Dr. Banu Anlar, Hacettepe University Faculty of Medicine, Department of Pediatric Neurology, Ankara 06100, Turkey.
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.